Emyria Ltd has released a press release.
Emyria to Develop Novel Psychedelics Pipeline with UWA
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria Advances EMD-004 Program Towards Registration
- Emyria Data Validated, Care Model Reduces Opioids
- Emyria Obtains TGA Approval for Medical Grade Monitoring App
- Emyria and MMA launch MDMA-assisted therapy program for PTSD
- $5m Placement for Drug Registration and Treatment Pipeline
Later from Emyria
- Emyria Executes Pure CBD Agreement with AltaSciences
- Emyria Appoints Expert Neuropharmacologist for MDMA Program
- Emyria Engages Calvert Labs for Preclinical CBD studies
- MDMA-analogues Show Promise for Parkinsons Disease
- Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria